Sulfotep

Sulfotep

SCHEMBL2336663

CCOP(=S)(OCC)OP(=S)(OCC)OCC.O=C(O)CCCCCCC(=O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 7/20 0.48
PPARD Q03181 7/20 0.48
PPARA Q07869 7/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 5/20 0.48
PTPN1 P18031 3/20 0.48
ALDH1A1 P00352 3/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
KMT2A Q03164 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48
MEN1 O00255 1/20 0.48
ESR1 P03372 1/20 0.48
ALOX15 P16050 1/20 0.48
PDE4A P27815 1/20 0.48
PDE3A Q14432 1/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfotep SCHEMBL2786434 1.00 GPR84 (0.48) GPR84PPARGPPARDPPARAHDAC11
Sulfotep SCHEMBL2026147 0.98 AKR1B1 (0.46) GPR84PPARGPPARDPPARAHDAC11
Sulfotep SCHEMBL8472533 0.95 GPR84 (0.59) GPR84PPARGPPARDPPARAHDAC11
Sulfotep SCHEMBL1163364 0.93 AKR1B1 (0.57) GPR84PPARGPPARDPPARAHDAC11
Sulfotep SCHEMBL1163969 0.91 AKR1B1 (0.48) GPR84PPARGPPARDPPARAHDAC11
Sulfotep SCHEMBL1163295 0.86 FFAR3 (0.52) GPR84PPARGPPARDPPARAHDAC11
Sulfotep SCHEMBL7767701 0.86 FFAR3 (0.52) GPR84PPARGPPARDPPARAHDAC11
Sulfotep SCHEMBL1163901 0.84 FFAR3 (0.46) PPARDTSHRALDH1A1TDP1KMT2A
Sulfotep SCHEMBL9651631 0.82 PPARD (0.39) PPARDTSHRALDH1A1TDP1KMT2A
Sulfotep SCHEMBL5016573 0.81 MEN1 (0.38) PPARDTSHRALDH1A1TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304468-B2 Polymers comprising thioester bonds DSM IP ASSETS B.V. (NL) 2012-11-06 US disclosed
US-20110301288-A1 THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS DSM IP ASSETS B.V. (NL) 2011-12-08 US disclosed
CN-102256938-A Thioic acids as building blocks for polythioesters DSM IP ASSETS BV 2011-11-23 CN disclosed
EP-2358668-A1 THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS DSM IP Assets B.V. (NL) 2011-08-24 EP disclosed
CN-101258183-B Polymers comprising thioester bonds DSM IP ASSETS BV 2011-01-26 CN disclosed
WO-2010070132-A1 THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS DSM IP ASSETS B.V. (NL) 2010-06-24 WO disclosed
EP-2199281-A1 Thioic acids as building block for polythioesters DSM IP Assets B.V. (NL) 2010-06-23 EP disclosed
US-20090156707-A1 Polymers comprising thioester bonds DSM IP ASSETS B.V. (NL) 2009-06-18 US disclosed
CN-101258183-A Polymers comprising thioester bonds DSM IP ASSETS BV (NL) 2008-09-03 CN disclosed
EP-1922351-A1 POLYMERS COMPRISING THIOESTER BONDS DSMIP Assets B.V. (NL) 2008-05-21 EP disclosed
WO-2007028612-A1 POLYMERS COMPRISING THIOESTER BONDS DSM IP ASSETS B.V. (NL) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110301288-A1 THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS OXER1, OXGR1, HPD GPR84 2096/4885PPARG 2314/4885PPARD 3119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.